search
Back to results

Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer

Primary Purpose

Breast Cancer, Psychosocial Effects of Cancer and Its Treatment, Sexual Dysfunction and Infertility

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
psychosocial assessment and care
Sponsored by
European Organisation for Research and Treatment of Cancer - EORTC
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional trial for Breast Cancer focused on measuring sexual dysfunction and infertility, sexuality and reproductive issues, psychosocial effects of cancer and its treatment, stage II breast cancer, stage IA breast cancer, stage IB breast cancer

Eligibility Criteria

undefined - 35 Years (Child, Adult)FemaleDoes not accept healthy volunteers

DISEASE CHARACTERISTICS: Histologically or cytologically confirmed prior or current diagnosis of breast cancer Stage I or II No relapsed disease No evidence of infertility Regular menses or regular hormonal contraception use for the past 3 months Hormonal status: Not specified PATIENT CHARACTERISTICS: Age 35 and under at diagnosis Sex Female Menopausal status Premenopausal Performance status Not specified Life expectancy Not specified Hematopoietic Not specified Hepatic Not specified Renal Not specified Other No psychological, familial, sociological, or geographical condition that would preclude study compliance PRIOR CONCURRENT THERAPY: Biologic therapy Not specified Chemotherapy Not specified Endocrine therapy See Disease Characteristics Radiotherapy Not specified Surgery Not specified

Sites / Locations

  • Institut Jules Bordet
  • Centre Hospitalier Etterbeek Ixelles
  • CHU Liege - Domaine Universitaire du Sart Tilman
  • Algemeen Ziekenhuis Sint-Augustinus
  • Instituto de Radiomedicina
  • Clinica Alemana
  • Hospital Militar
  • University Hospital Rebro
  • Klinikum der J.W. Goethe Universitaet
  • Universitatsklinikum Heidelberg
  • Centro di Riferimento Oncologico - Aviano
  • Azienda Istituti Ospitalieri
  • Ospedale Alessandro Manzoni
  • European Institute of Oncology
  • American University of Beirut Medical Center
  • Academisch Medisch Centrum at University of Amsterdam
  • Arnhems Radiotherapeutisch Instituut
  • Instituto Nacional de Enfermedades Neoplasicas
  • Medical University of Gdansk
  • Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, SA
  • Institute of Oncology and Radiology of Serbia
  • Groote Schuur Hospital
  • Inselspital Bern
  • Ospedale Beata Vergine
  • Kantonsspital - St. Gallen
  • Marmara University Hospital
  • Western Infirmary

Outcomes

Primary Outcome Measures

Patients who would agree to have chemotherapy if it reduces their chances of having children as assessed by questionnaire

Secondary Outcome Measures

Full Information

First Posted
June 5, 2003
Last Updated
October 23, 2013
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
German Adjuvant Breast Cancer Group, ETOP IBCSG Partners Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00062400
Brief Title
Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
Official Title
A Survey of the Breast International Group (B.I.G.) to Assess the Attitude of Patients Aged Less Than 35 Years, With Early Breast Cancer, Toward the Risk of Loss of Fertility Related to Adjuvant Therapies
Study Type
Interventional

2. Study Status

Record Verification Date
October 2013
Overall Recruitment Status
Completed
Study Start Date
May 2003 (undefined)
Primary Completion Date
June 2008 (Actual)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
German Adjuvant Breast Cancer Group, ETOP IBCSG Partners Foundation

4. Oversight

5. Study Description

Brief Summary
RATIONALE: Adjuvant therapy given after surgery for early breast cancer may cause infertility. Assessing young women's attitudes and feelings about the risk of infertility may help improve the ability to plan effective treatment. PURPOSE: This clinical trial is studying young women's attitudes and feelings about the risk of infertility related to adjuvant therapy for stage I or stage II breast cancer.
Detailed Description
OBJECTIVES: Determine the attitude toward the risk of infertility related to adjuvant therapy in women with early breast cancer. Correlate, if possible, the patient's attitude with the fact that the patient already has children or the time interval between the date of breast cancer diagnosis and the date of study participation. OUTLINE: This is a multicenter study. Patients complete a questionnaire administered by a nontreating physician. PROJECTED ACCRUAL: A total of 385 patients will be accrued for this study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Psychosocial Effects of Cancer and Its Treatment, Sexual Dysfunction and Infertility, Sexuality and Reproductive Issues
Keywords
sexual dysfunction and infertility, sexuality and reproductive issues, psychosocial effects of cancer and its treatment, stage II breast cancer, stage IA breast cancer, stage IB breast cancer

7. Study Design

Study Phase
Not Applicable
Enrollment
385 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
psychosocial assessment and care
Primary Outcome Measure Information:
Title
Patients who would agree to have chemotherapy if it reduces their chances of having children as assessed by questionnaire

10. Eligibility

Sex
Female
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
DISEASE CHARACTERISTICS: Histologically or cytologically confirmed prior or current diagnosis of breast cancer Stage I or II No relapsed disease No evidence of infertility Regular menses or regular hormonal contraception use for the past 3 months Hormonal status: Not specified PATIENT CHARACTERISTICS: Age 35 and under at diagnosis Sex Female Menopausal status Premenopausal Performance status Not specified Life expectancy Not specified Hematopoietic Not specified Hepatic Not specified Renal Not specified Other No psychological, familial, sociological, or geographical condition that would preclude study compliance PRIOR CONCURRENT THERAPY: Biologic therapy Not specified Chemotherapy Not specified Endocrine therapy See Disease Characteristics Radiotherapy Not specified Surgery Not specified
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zora Neskovic-Konstantinovic
Organizational Affiliation
Institute Of Oncology & Radiology, Belgrade, Serbia
Official's Role
Study Chair
Facility Information:
Facility Name
Institut Jules Bordet
City
Brussels
ZIP/Postal Code
1000
Country
Belgium
Facility Name
Centre Hospitalier Etterbeek Ixelles
City
Brussels
ZIP/Postal Code
B-1050
Country
Belgium
Facility Name
CHU Liege - Domaine Universitaire du Sart Tilman
City
Liege
ZIP/Postal Code
B-4000
Country
Belgium
Facility Name
Algemeen Ziekenhuis Sint-Augustinus
City
Wilrijk
ZIP/Postal Code
2610
Country
Belgium
Facility Name
Instituto de Radiomedicina
City
Santiago
ZIP/Postal Code
10
Country
Chile
Facility Name
Clinica Alemana
City
Santiago
ZIP/Postal Code
5951
Country
Chile
Facility Name
Hospital Militar
City
Santiago
Country
Chile
Facility Name
University Hospital Rebro
City
Zagreb
ZIP/Postal Code
41000
Country
Croatia
Facility Name
Klinikum der J.W. Goethe Universitaet
City
Frankfurt
ZIP/Postal Code
D-60590
Country
Germany
Facility Name
Universitatsklinikum Heidelberg
City
Heidelberg
ZIP/Postal Code
69115
Country
Germany
Facility Name
Centro di Riferimento Oncologico - Aviano
City
Aviano
ZIP/Postal Code
33081
Country
Italy
Facility Name
Azienda Istituti Ospitalieri
City
Cremona
ZIP/Postal Code
26100
Country
Italy
Facility Name
Ospedale Alessandro Manzoni
City
Lecco
ZIP/Postal Code
23900
Country
Italy
Facility Name
European Institute of Oncology
City
Milan
ZIP/Postal Code
20141
Country
Italy
Facility Name
American University of Beirut Medical Center
City
Beirut
ZIP/Postal Code
113-6044
Country
Lebanon
Facility Name
Academisch Medisch Centrum at University of Amsterdam
City
Amsterdam
ZIP/Postal Code
1105 AZ
Country
Netherlands
Facility Name
Arnhems Radiotherapeutisch Instituut
City
Arnhem
ZIP/Postal Code
6815 AD
Country
Netherlands
Facility Name
Instituto Nacional de Enfermedades Neoplasicas
City
Lima
ZIP/Postal Code
34
Country
Peru
Facility Name
Medical University of Gdansk
City
Gdansk
ZIP/Postal Code
80-211
Country
Poland
Facility Name
Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, SA
City
Lisboa
ZIP/Postal Code
1099-023 Codex
Country
Portugal
Facility Name
Institute of Oncology and Radiology of Serbia
City
Belgrade
ZIP/Postal Code
11000
Country
Serbia
Facility Name
Groote Schuur Hospital
City
Cape Town
ZIP/Postal Code
7925
Country
South Africa
Facility Name
Inselspital Bern
City
Bern
ZIP/Postal Code
CH-3010
Country
Switzerland
Facility Name
Ospedale Beata Vergine
City
Mendrisio
ZIP/Postal Code
CH-6850
Country
Switzerland
Facility Name
Kantonsspital - St. Gallen
City
St. Gallen
ZIP/Postal Code
CH-9007
Country
Switzerland
Facility Name
Marmara University Hospital
City
Istanbul
ZIP/Postal Code
81190
Country
Turkey
Facility Name
Western Infirmary
City
Glasgow
State/Province
Scotland
ZIP/Postal Code
G11 6NT
Country
United Kingdom

12. IPD Sharing Statement

Citations:
Citation
Neskovic-Konstantinovic Z, Gomez H, Senkus-Konefka E, et al.: A Breast International Group survey of young breast cancer patients attitudes towards the risk of loss of fertility related to adjuvant therapies: EORTC protocol 10002 - BIG 3-98. [Abstract] 31st Annual San Antonio Breast Cancer Symposium, December 10-14, 2008, San Antonio, Texas. A-3106, 2008.
Results Reference
result

Learn more about this trial

Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer

We'll reach out to this number within 24 hrs